Drug Name: 

ALIROCUMAB*

Drug Description: 
PCSK9 Antibody
Target Condition: 
LDL cholesterol, cardiovascular events
Rank: 
10
Phase: 
Phase 3

NOW APPROVED IN THE UNITED STATES

Learn more